APA (7th ed.) Citation

Miyauchi, A., Hamaya, E., Yang, W., Nishi, K., Libanati, C., Tolman, C., & Shimauchi, J. (2021). Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial. Journal of bone and mineral metabolism, 39(2), 278-288. https://doi.org/10.1007/s00774-020-01147-5

Chicago Style (17th ed.) Citation

Miyauchi, Akimitsu, Etsuro Hamaya, Wenjing Yang, Kiyoshi Nishi, Cesar Libanati, Cae Tolman, and Junichiro Shimauchi. "Romosozumab Followed by Denosumab in Japanese Women with High Fracture Risk in the FRAME Trial." Journal of Bone and Mineral Metabolism 39, no. 2 (2021): 278-288. https://doi.org/10.1007/s00774-020-01147-5.

MLA (9th ed.) Citation

Miyauchi, Akimitsu, et al. "Romosozumab Followed by Denosumab in Japanese Women with High Fracture Risk in the FRAME Trial." Journal of Bone and Mineral Metabolism, vol. 39, no. 2, 2021, pp. 278-288, https://doi.org/10.1007/s00774-020-01147-5.